首页 > 最新文献

Dermatology Research and Practice最新文献

英文 中文
Dermoscopic Features of Psoriatic Nails and Their Correlation to Disease Severity. 银屑病指甲的皮肤镜特征及其与病情严重程度的关系。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/4653177
Zeinab R Mashal, Emad Eldin A Elgamal, Mohamed S Zaky, Mohamed L Elsaie

Background: Nail psoriasis is a challenging chronic condition affecting patients functionally and psychologically. Nail involvement is observed in 15-80% of psoriatic patients with occasional presence of isolated nail psoriasis.

Objectives: To evaluate dermoscopic features of nail psoriasis and correlate them clinically.

Methods: The study included fifty subjects with nail psoriasis. Psoriasis skin and nail severity was evaluated using psoriasis area severity index (PASI) and nail psoriasis severity index (NAPSI). Dermoscopy of the nails (onychoscopy) was performed, and features were recorded and analyzed.

Results: The most common clinical and dermoscopic findings were pitting (86%) and onycholysis (82%). Among all dermoscopic features of nail psoriasis, only longitudinal striations and subungual hyperkeratosis were significantly higher in patients with moderate to severe psoriasis than in patients with mild psoriasis (P=0.028; P=0.042, respectively). PASI scores correlated positively but none significantly with NAPSI scores (r = 0.132, P=0.360), and similarly, no significant correlation was observed between the duration of psoriasis and the dermoscopic NAPSI (r = 0.022, P=0.879).

Conclusion: Dermoscopy can serve as a useful tool for early diagnosis of psoriatic nail changes not always visible to the naked eye and is a non-invasive easy-to-use confirmatory tool for nail changes in psoriatic disease or in isolated nail involvement.

背景:甲牛皮癣是一种具有挑战性的慢性疾病,影响患者的功能和心理。在15-80%的银屑病患者中观察到指甲受累,偶尔存在孤立的指甲银屑病。目的:探讨甲型银屑病的皮肤镜特征及其临床相关性。方法:对50例甲癣患者进行研究。采用银屑病面积严重指数(PASI)和指甲银屑病严重指数(NAPSI)评价银屑病皮肤和指甲的严重程度。行甲皮镜检查(甲镜检查),记录特征并分析。结果:最常见的临床和皮肤镜表现为凹陷(86%)和骨髓炎(82%)。在甲型银屑病的所有皮肤镜特征中,中重度银屑病患者只有纵向条纹和甲下角化过度明显高于轻度银屑病患者(P=0.028;分别为P = 0.042)。PASI评分与NAPSI评分呈正相关,但无显著相关性(r = 0.132, P=0.360),同样,银屑病病程与皮肤镜下NAPSI评分无显著相关性(r = 0.022, P=0.879)。结论:皮肤镜检查可作为银屑病指甲变化的早期诊断工具,对银屑病或孤立性指甲受累的指甲变化是一种无创、易于使用的确诊工具。
{"title":"Dermoscopic Features of Psoriatic Nails and Their Correlation to Disease Severity.","authors":"Zeinab R Mashal,&nbsp;Emad Eldin A Elgamal,&nbsp;Mohamed S Zaky,&nbsp;Mohamed L Elsaie","doi":"10.1155/2023/4653177","DOIUrl":"https://doi.org/10.1155/2023/4653177","url":null,"abstract":"<p><strong>Background: </strong>Nail psoriasis is a challenging chronic condition affecting patients functionally and psychologically. Nail involvement is observed in 15-80% of psoriatic patients with occasional presence of isolated nail psoriasis.</p><p><strong>Objectives: </strong>To evaluate dermoscopic features of nail psoriasis and correlate them clinically.</p><p><strong>Methods: </strong>The study included fifty subjects with nail psoriasis. Psoriasis skin and nail severity was evaluated using psoriasis area severity index (PASI) and nail psoriasis severity index (NAPSI). Dermoscopy of the nails (onychoscopy) was performed, and features were recorded and analyzed.</p><p><strong>Results: </strong>The most common clinical and dermoscopic findings were pitting (86%) and onycholysis (82%). Among all dermoscopic features of nail psoriasis, only longitudinal striations and subungual hyperkeratosis were significantly higher in patients with moderate to severe psoriasis than in patients with mild psoriasis (<i>P</i>=0.028; <i>P</i>=0.042, respectively). PASI scores correlated positively but none significantly with NAPSI scores (<i>r</i> = 0.132, <i>P</i>=0.360), and similarly, no significant correlation was observed between the duration of psoriasis and the dermoscopic NAPSI (<i>r</i> = 0.022, <i>P</i>=0.879).</p><p><strong>Conclusion: </strong>Dermoscopy can serve as a useful tool for early diagnosis of psoriatic nail changes not always visible to the naked eye and is a non-invasive easy-to-use confirmatory tool for nail changes in psoriatic disease or in isolated nail involvement.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2023 ","pages":"4653177"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9871498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia. 沙特阿拉伯三级医疗中心的严重皮肤药物不良反应。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/8928198
Mohammed I AlJasser

Background: Severe cutaneous adverse drug reactions (SCARs), although rare, are known to be associated with significant morbidity and mortality. SCARs include drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), and acute generalized exanthematous pustulosis (AGEP). Studies on SCARs are limited in Saudi Arabia. This study aims to characterize SCARs at a tertiary care center in Saudi Arabia.

Methods: A cross-sectional study was conducted at King Abdulaziz Medical City, Riyadh, Saudi Arabia. All inpatient and emergency department consultations to dermatology were electronically reviewed during the period from January 2016 to December 2020. All patients who developed an adverse cutaneous drug reaction were enrolled. Detailed analysis was performed only for SCARs. The culprit medication was determined based on the latency period, history of previous intake of the medication, and drug notoriety.

Results: There were 3050 hospital consultations to dermatology during the study period. Cutaneous adverse drug reactions constituted 253 (8.3%) cases. A total of 41 patients with SCARs were identified, accounting for 16.2% of all cutaneous drug reactions. Antibiotics and anticonvulsants were the most common causative drug groups accounting for 28 (68.3%) and 9 (22%) cases, respectively. DRESS was the most common SCAR. The latency period was the longest for DRESS and shortest for AGEP. Vancomycin was responsible for approximately a third of DRESS cases. Piperacillin/tazobactam was the most common cause for SJS/TEN and AGEP. The majority of drugs causing AGEP were antibiotics. The mortality rate was the highest in SJS/TEN (5/11 (45.5%)), followed by DRESS (1/23 (4.4%)) and AGEP (1/7 (14.3%)).

Conclusion: SCARs are rare in Saudis. DRESS appears to be the most common SCAR in our region. Vancomycin is responsible for most cases of DRESS. SJS/TEN had the highest mortality rate. More studies are required to further characterize SCARs in Saudi Arabia and Arabian Gulf countries. More importantly, thorough studies of HLA associations and lymphocyte transformation tests among Arabs with SCARs are likely to further improve patient care in the Arabian Gulf region.

背景:严重皮肤药物不良反应(scar)虽然罕见,但已知与显著的发病率和死亡率相关。疤痕包括嗜酸性粒细胞增多和全身症状的药物反应(DRESS)、Stevens-Johnson综合征/中毒性表皮坏死松解(SJS/TEN)和急性全身性脓疱病(AGEP)。沙特阿拉伯对scar的研究有限。本研究的目的是表征疤痕在沙特阿拉伯三级保健中心。方法:在沙特阿拉伯利雅得阿卜杜勒阿齐兹国王医疗城进行横断面研究。2016年1月至2020年12月期间,所有皮肤科住院和急诊科会诊均以电子方式进行审查。所有出现皮肤药物不良反应的患者均被纳入研究。仅对scar进行了详细分析。根据潜伏期、既往用药史和药物恶名来确定罪魁祸首药物。结果:研究期间共有3050例皮肤科就诊。皮肤药物不良反应253例(8.3%)。共发现41例瘢痕患者,占所有皮肤药物反应的16.2%。抗生素和抗惊厥药是最常见的致痫药物,分别占28例(68.3%)和9例(22%)。DRESS是最常见的疤痕。DRESS的潜伏期最长,AGEP的潜伏期最短。万古霉素导致了大约三分之一的DRESS病例。哌拉西林/他唑巴坦是SJS/TEN和AGEP的最常见原因。引起AGEP的药物以抗生素为主。SJS/TEN的死亡率最高(5/11(45.5%)),其次是DRESS(1/23(4.4%))和AGEP(1/7(14.3%))。结论:瘢痕在沙特罕见。DRESS似乎是我们地区最常见的SCAR。万古霉素是大多数DRESS病例的病因。SJS/TEN的死亡率最高。需要更多的研究来进一步表征沙特阿拉伯和阿拉伯海湾国家的疤痕。更重要的是,对阿拉伯人的HLA相关性和淋巴细胞转化试验的深入研究可能会进一步改善阿拉伯海湾地区的患者护理。
{"title":"Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia.","authors":"Mohammed I AlJasser","doi":"10.1155/2023/8928198","DOIUrl":"https://doi.org/10.1155/2023/8928198","url":null,"abstract":"<p><strong>Background: </strong>Severe cutaneous adverse drug reactions (SCARs), although rare, are known to be associated with significant morbidity and mortality. SCARs include drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), and acute generalized exanthematous pustulosis (AGEP). Studies on SCARs are limited in Saudi Arabia. This study aims to characterize SCARs at a tertiary care center in Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted at King Abdulaziz Medical City, Riyadh, Saudi Arabia. All inpatient and emergency department consultations to dermatology were electronically reviewed during the period from January 2016 to December 2020. All patients who developed an adverse cutaneous drug reaction were enrolled. Detailed analysis was performed only for SCARs. The culprit medication was determined based on the latency period, history of previous intake of the medication, and drug notoriety.</p><p><strong>Results: </strong>There were 3050 hospital consultations to dermatology during the study period. Cutaneous adverse drug reactions constituted 253 (8.3%) cases. A total of 41 patients with SCARs were identified, accounting for 16.2% of all cutaneous drug reactions. Antibiotics and anticonvulsants were the most common causative drug groups accounting for 28 (68.3%) and 9 (22%) cases, respectively. DRESS was the most common SCAR. The latency period was the longest for DRESS and shortest for AGEP. Vancomycin was responsible for approximately a third of DRESS cases. Piperacillin/tazobactam was the most common cause for SJS/TEN and AGEP. The majority of drugs causing AGEP were antibiotics. The mortality rate was the highest in SJS/TEN (5/11 (45.5%)), followed by DRESS (1/23 (4.4%)) and AGEP (1/7 (14.3%)).</p><p><strong>Conclusion: </strong>SCARs are rare in Saudis. DRESS appears to be the most common SCAR in our region. Vancomycin is responsible for most cases of DRESS. SJS/TEN had the highest mortality rate. More studies are required to further characterize SCARs in Saudi Arabia and Arabian Gulf countries. More importantly, thorough studies of HLA associations and lymphocyte transformation tests among Arabs with SCARs are likely to further improve patient care in the Arabian Gulf region.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2023 ","pages":"8928198"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9490582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Open-Label Observational Study of a Topical Formulation of Calcium Spirulan Contained in a Defined Extract of the Microalga Spirulina platensis in the Treatment of Children with Molluscum Contagiosum. 一种限定的螺旋藻提取物中含有的局部螺旋藻钙制剂用于治疗儿童传染性软疣的开放标签观察研究。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1155/2023/8871299
Karoline Jungclaus, Rosa Mascarenhas, Oscar Tellechea, Jeremias L K Reich, Kristian Reich

Background: Molluscum contagiosum (MC) is a common viral skin infection primarily affecting children which is difficult to treat using available therapeutic approaches. The sulfated polysaccharide named calcium spirulan (Ca-SP) has demonstrated antiviral effects against herpes simplex virus in keratinocytes in vitro, and a cream containing 1.5% Ca-SP and 1% of a defined microalgae extract (Spiralin®) effectively prevented herpes labialis in a trial with susceptible individuals. This observational study aimed to show antiviral effects of a similar formulation (Spirularin® VS) against MC in children.

Methods: Children with active MC lesions were treated with Spirularin® VS cream twice daily on affected skin over several months and asked to return for follow-up visits after 1 to 3 months. Clinical status of MC infection was documented at baseline and follow-up visits.

Results: Of the 31 children enrolled in the study, 26 completed treatment and returned for control visits. Spirularin® VS cream was applied twice daily over a period of 1 to 9 months (mean treatment duration 3.9 months). 19/26 (73.1%) children achieved complete clearance of MC lesions with no clinical evidence of bacterial skin infection during treatment. No irritative skin reactions or unpleasant symptoms were observed or reported.

Conclusion: This open-label observational study suggests that a cream formulation containing 1.5% Ca-SP and 1% Spiralin® may be an effective and safe treatment option for children with active MC lesions. The high rate of complete clearance of MC lesions and lack of adverse reactions warrant further investigation in larger, controlled trials.

背景:传染性软疣(MC)是一种常见的病毒性皮肤感染,主要影响儿童,使用现有的治疗方法很难治疗。一种名为螺旋藻钙(Ca-SP)的硫酸酸化多糖在体外角质形成细胞中显示出对单纯疱疹病毒的抗病毒作用,一种含有1.5% Ca-SP和1%特定微藻提取物(Spiralin®)的乳膏在易感个体的试验中有效地预防了唇疱疹。本观察性研究旨在显示一种类似制剂(Spirularin®VS)对儿童MC的抗病毒作用。方法:对患有活动性MC病变的儿童使用Spirularin®VS乳膏治疗,每天2次,持续数月,并于1至3个月后返回随访。在基线和随访时记录MC感染的临床状况。结果:参与研究的31名儿童中,26名完成了治疗并返回对照组。Spirularin®VS乳膏每日两次,持续1至9个月(平均治疗时间3.9个月)。19/26(73.1%)的患儿在治疗过程中完全清除了MC病变,无临床证据表明存在细菌性皮肤感染。没有观察到或报告刺激性皮肤反应或不愉快的症状。结论:这项开放标签观察性研究表明,含有1.5% Ca-SP和1% Spiralin®的乳膏制剂可能是活动性MC病变儿童的有效和安全的治疗选择。MC病变的高完全清除率和缺乏不良反应值得在更大的对照试验中进一步研究。
{"title":"Open-Label Observational Study of a Topical Formulation of Calcium Spirulan Contained in a Defined Extract of the Microalga <i>Spirulina platensis</i> in the Treatment of Children with Molluscum Contagiosum.","authors":"Karoline Jungclaus,&nbsp;Rosa Mascarenhas,&nbsp;Oscar Tellechea,&nbsp;Jeremias L K Reich,&nbsp;Kristian Reich","doi":"10.1155/2023/8871299","DOIUrl":"https://doi.org/10.1155/2023/8871299","url":null,"abstract":"<p><strong>Background: </strong>Molluscum contagiosum (MC) is a common viral skin infection primarily affecting children which is difficult to treat using available therapeutic approaches. The sulfated polysaccharide named calcium spirulan (Ca-SP) has demonstrated antiviral effects against herpes simplex virus in keratinocytes <i>in vitro</i>, and a cream containing 1.5% Ca-SP and 1% of a defined microalgae extract (Spiralin<sup>®</sup>) effectively prevented herpes labialis in a trial with susceptible individuals. This observational study aimed to show antiviral effects of a similar formulation (Spirularin<sup>®</sup> VS) against MC in children.</p><p><strong>Methods: </strong>Children with active MC lesions were treated with Spirularin<sup>®</sup> VS cream twice daily on affected skin over several months and asked to return for follow-up visits after 1 to 3 months. Clinical status of MC infection was documented at baseline and follow-up visits.</p><p><strong>Results: </strong>Of the 31 children enrolled in the study, 26 completed treatment and returned for control visits. Spirularin<sup>®</sup> VS cream was applied twice daily over a period of 1 to 9 months (mean treatment duration 3.9 months). 19/26 (73.1%) children achieved complete clearance of MC lesions with no clinical evidence of bacterial skin infection during treatment. No irritative skin reactions or unpleasant symptoms were observed or reported.</p><p><strong>Conclusion: </strong>This open-label observational study suggests that a cream formulation containing 1.5% Ca-SP and 1% Spiralin® may be an effective and safe treatment option for children with active MC lesions. The high rate of complete clearance of MC lesions and lack of adverse reactions warrant further investigation in larger, controlled trials.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2023 ","pages":"8871299"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10349975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources. 资源有限的国家治疗真菌病的建议指南。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/1360740
Mona Abdel-Halim Ibrahim, Nada Eltayeb, Mirna Michel Ibrahim, Ahmed Nassar, Maged Daruish, Maha El-Zimaity, Mahmoud El-Lithy, Ahmed Mostafa, Amal El-Afifi, Haitham Abdelbary, Mahira Hamdy El-Sayed

The treatment options for mycosis fungoides (MF) have been expanding but unfortunately many of the currently used treatment modalities are unavailable in Egypt and other African/Arab countries. In addition, there is a lack of consensus on the treatment of hypopigmented MF (HMF), which is a frequently encountered variant in our population. We aimed to develop regional treatment guidelines based on the international guidelines but modified to encompass the restricted treatment availability and our institutional experience. Special attention was also given to studies conducted on patients with skin phototype (III-IV). Treatment algorithm was formulated at Ain-Shams cutaneous lymphoma clinic through the collaboration of dermatologists, haematologists, and oncologists. Level of evidence is specified for each treatment option. For HMF, phototherapy is recommended as a first line treatment, while low-dose methotrexate is considered a second line. For early classical MF, we recommend Psoralen-ultraviolet A (PUVA), which is a well-tolerated treatment option in dark phenotype. Addition of either retinoic acid receptor (RAR) agonist and/or methotrexate is recommended as a second line. Total skin electron beam (TSEB) is considered a third-line option. For advanced stage, PUVA plus RAR agonist and/or methotrexate is recommended as first line, TSEB or monochemotherapy is considered a second line option. Polychemotherapy is regarded as a final option. All patients with complete response (CR) enter a maintenance and follow-up schedule. We suggest a practical algorithm for the treatment of MF for patients with dark phenotype living in countries with limited resources.

蕈样真菌病(MF)的治疗选择一直在扩大,但不幸的是,许多目前使用的治疗方式在埃及和其他非洲/阿拉伯国家无法获得。此外,对于低色素MF (HMF)的治疗缺乏共识,这是我们人群中经常遇到的变体。我们的目标是在国际指南的基础上制定区域治疗指南,但对其进行了修改,以涵盖有限的治疗可用性和我们的机构经验。对皮肤光型(III-IV)患者的研究也给予了特别关注。Ain-Shams皮肤淋巴瘤诊所通过皮肤科医生、血液科医生和肿瘤科医生的合作制定了治疗方案。每种治疗方案都规定了证据水平。对于HMF,推荐光疗作为一线治疗,而低剂量甲氨蝶呤则被认为是二线治疗。对于早期经典MF,我们推荐补骨脂素-紫外线A (PUVA),这是一种耐受性良好的治疗选择。推荐添加视黄酸受体(RAR)激动剂和/或甲氨蝶呤作为二线治疗。全皮肤电子束(TSEB)被认为是第三线选择。对于晚期,建议将PUVA + RAR激动剂和/或甲氨蝶呤作为一线,TSEB或单一化疗被认为是二线选择。多重化疗被认为是最后的选择。所有完全缓解(CR)的患者进入维持和随访计划。我们提出了一种实用的算法,用于治疗生活在资源有限的国家的黑暗表型患者的MF。
{"title":"Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources.","authors":"Mona Abdel-Halim Ibrahim,&nbsp;Nada Eltayeb,&nbsp;Mirna Michel Ibrahim,&nbsp;Ahmed Nassar,&nbsp;Maged Daruish,&nbsp;Maha El-Zimaity,&nbsp;Mahmoud El-Lithy,&nbsp;Ahmed Mostafa,&nbsp;Amal El-Afifi,&nbsp;Haitham Abdelbary,&nbsp;Mahira Hamdy El-Sayed","doi":"10.1155/2023/1360740","DOIUrl":"https://doi.org/10.1155/2023/1360740","url":null,"abstract":"<p><p>The treatment options for mycosis fungoides (MF) have been expanding but unfortunately many of the currently used treatment modalities are unavailable in Egypt and other African/Arab countries. In addition, there is a lack of consensus on the treatment of hypopigmented MF (HMF), which is a frequently encountered variant in our population. We aimed to develop regional treatment guidelines based on the international guidelines but modified to encompass the restricted treatment availability and our institutional experience. Special attention was also given to studies conducted on patients with skin phototype (III-IV). Treatment algorithm was formulated at Ain-Shams cutaneous lymphoma clinic through the collaboration of dermatologists, haematologists, and oncologists. Level of evidence is specified for each treatment option. For HMF, phototherapy is recommended as a first line treatment, while low-dose methotrexate is considered a second line. For early classical MF, we recommend Psoralen-ultraviolet A (PUVA), which is a well-tolerated treatment option in dark phenotype. Addition of either retinoic acid receptor (RAR) agonist and/or methotrexate is recommended as a second line. Total skin electron beam (TSEB) is considered a third-line option. For advanced stage, PUVA plus RAR agonist and/or methotrexate is recommended as first line, TSEB or monochemotherapy is considered a second line option. Polychemotherapy is regarded as a final option. All patients with complete response (CR) enter a maintenance and follow-up schedule. We suggest a practical algorithm for the treatment of MF for patients with dark phenotype living in countries with limited resources.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2023 ","pages":"1360740"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9242045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata. 伊拉克斑秃患者白细胞介素-15与肿瘤坏死因子-α的关系。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/5109772
Zainab A Kamil, Galawish A Abdullah, Haider Hashim Zalzala

Background: Alopecia areata (AA) is a common form of noncicatricial hair loss of unknown cause, affecting 0.1-0.2% of the general population. Most evidence supports the hypothesis that it is disease of the hair follicle of autoimmune nature mediated by T-cells, with important cytokine role. Objective of the Study. The objective of this study is to study the association and changes in serum levels of interleukin-15 (IL-15) and tumor necrosis factor-α (TNF-α) in patients with AA in relation to the type, activity, and disease duration. Patients and Methods. Thirty-eight patients with AA and 22 individuals without the disease as controls were enrolled in this case-controlled study conducted in the Department of Dermatology in the Al-Kindy Teaching Hospital and Baghdad Medical City, Iraq, during a period from the 1st of April 2021 to the 1st of December 2021. Serum concentrations of IL-15 and TNF-α assessed using the enzyme-linked immunosorbent assay.

Results: The mean serum concentration values for IL-15 and TNF-α were higher significantly in patients with AA than in controls (2.35 versus 0.35 pg/mL and 50.11 versus 20.92 pg/mL, respectively). IL-15 and TNF-α showed no statistically significant differences in level in terms of the type, duration, and activity of the disease, but TNF-α significantly higher in those with totalis-type than in other types.

Conclusion: Both IL-15 and TNF-α are markers for alopecia areata. The level for these biomarkers was not affected by duration or disease activity, but it was affected by the type of disease, as the concentrations of IL-15 and TNF-α were higher in patient with Alopecia totalis than in other types of Alopecia.

背景:斑秃(AA)是一种常见的原因不明的非瘢痕性脱发,约占总人口的0.1-0.2%。大多数证据支持这一假设,即它是由t细胞介导的自身免疫性毛囊疾病,具有重要的细胞因子作用。研究目的:本研究旨在探讨AA患者血清白细胞介素-15 (IL-15)和肿瘤坏死因子-α (TNF-α)水平与AA类型、活动性和病程的相关性及变化。患者和方法。这项病例对照研究于2021年4月1日至2021年12月1日在伊拉克Al-Kindy教学医院和巴格达医疗城皮肤科进行,纳入了38名AA患者和22名非AA患者作为对照。采用酶联免疫吸附法测定血清IL-15和TNF-α浓度。结果:AA患者血清IL-15和TNF-α的平均浓度值明显高于对照组(分别为2.35 vs 0.35 pg/mL和50.11 vs 20.92 pg/mL)。IL-15和TNF-α在疾病类型、病程和活动性方面差异无统计学意义,但TNF-α在全型患者中明显高于其他类型。结论:IL-15和TNF-α是斑秃的标志物。这些生物标志物的水平不受病程或疾病活动的影响,但受疾病类型的影响,因为全秃患者的IL-15和TNF-α浓度高于其他类型的脱发。
{"title":"Interleukin-15 and Tumor Necrosis Factor-<i>α</i> in Iraqi Patients with Alopecia Areata.","authors":"Zainab A Kamil,&nbsp;Galawish A Abdullah,&nbsp;Haider Hashim Zalzala","doi":"10.1155/2023/5109772","DOIUrl":"https://doi.org/10.1155/2023/5109772","url":null,"abstract":"<p><strong>Background: </strong>Alopecia areata (AA) is a common form of noncicatricial hair loss of unknown cause, affecting 0.1-0.2% of the general population. Most evidence supports the hypothesis that it is disease of the hair follicle of autoimmune nature mediated by T-cells, with important cytokine role. <i>Objective of the Study</i>. The objective of this study is to study the association and changes in serum levels of interleukin-15 (IL-15) and tumor necrosis factor-<i>α</i> (TNF-<i>α</i>) in patients with AA in relation to the type, activity, and disease duration. <i>Patients and Methods</i>. Thirty-eight patients with AA and 22 individuals without the disease as controls were enrolled in this case-controlled study conducted in the Department of Dermatology in the Al-Kindy Teaching Hospital and Baghdad Medical City, Iraq, during a period from the 1st of April 2021 to the 1st of December 2021. Serum concentrations of IL-15 and TNF-<i>α</i> assessed using the enzyme-linked immunosorbent assay.</p><p><strong>Results: </strong>The mean serum concentration values for IL-15 and TNF-<i>α</i> were higher significantly in patients with AA than in controls (2.35 versus 0.35 pg/mL and 50.11 versus 20.92 pg/mL, respectively). IL-15 and TNF-<i>α</i> showed no statistically significant differences in level in terms of the type, duration, and activity of the disease, but TNF-<i>α</i> significantly higher in those with totalis-type than in other types.</p><p><strong>Conclusion: </strong>Both IL-15 and TNF-<i>α</i> are markers for alopecia areata. The level for these biomarkers was not affected by duration or disease activity, but it was affected by the type of disease, as the concentrations of IL-15 and TNF-<i>α</i> were higher in patient with Alopecia totalis than in other types of Alopecia.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":"2023 ","pages":"5109772"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9497936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone versus Oral Methotrexate in Patients with Lichen Planopilaris. 口服甲氨蝶呤联合强的松龙与口服甲氨蝶呤治疗扁平苔藓的疗效比较研究。
IF 1.5 Q2 Medicine Pub Date : 2022-10-08 eCollection Date: 2022-01-01 DOI: 10.1155/2022/3792489
Farahnaz Fatemi, Farifteh Esfahanian, Ali Asilian, Fatemeh Mohaghegh, Mina Saber

Background: Lichen planopilaris (LPP) is a rare inflammatory disorder of the scalp that causes cicatricial alopecia. No therapeutic approach has been approved for this disease due to the rare frequency. Methotrexate and corticosteroid are commonly considered second- or third-line therapy. The efficacy of a combination of methotrexate and corticosteroid has been reported in some dermatological and immunological diseases. However, the efficacy of this combination in LPP is not clear. Therefore, this study aimed to compare the impact of methotrexate alone and in combination with corticosteroid on LPP.

Materials and methods: This randomized clinical trial was performed on 28 patients who referred to the dermatology clinic affiliated with Isfahan University of Medical Sciences, Isfahan, Iran during February 2015-December 2016, and 24 of them completed the trials. Fourteen patients received 15 mg methotrexate per week alone and the other fourteen subjects received 200 mg prednisolone plus 15 mg methotrexate per week. The primary outcome was Lichen planopilaris activity index (LPPAI) score. Moreover, we evaluated photographic changes and symptoms during the study.

Results: The mean of LPPAI in both groups decreased during the follow-up with a similar pattern of LPPAI changes in both groups. No statistically significant difference was found between the two intervention groups regarding the LPPAI score. We found no difference in the symptoms and photographic assessments in methotrexate and combination therapy groups during follow-up. In both groups, exclusively one adverse effect was reported.

Conclusions: Our results showed that methotrexate therapy with and without corticosteroids had similar efficacy and safety.

背景:扁平毛癣(LPP)是一种罕见的头皮炎症性疾病,可引起瘢痕性脱发。由于罕见的发病率,尚无治疗方法被批准。甲氨蝶呤和皮质类固醇通常被认为是二线或三线治疗。甲氨蝶呤和皮质类固醇联合治疗一些皮肤病和免疫病的疗效已被报道。然而,这种联合治疗LPP的疗效尚不清楚。因此,本研究旨在比较单用甲氨蝶呤和联用皮质类固醇对LPP的影响。材料与方法:本随机临床试验于2015年2月至2016年12月在伊朗伊斯法罕医学大学附属皮肤科诊所就诊的28例患者进行,其中24例完成试验。14例患者每周单独接受15mg甲氨蝶呤治疗,另外14例患者每周接受200mg强的松龙加15mg甲氨蝶呤治疗。主要观察指标为扁平苔藓活动指数(LPPAI)评分。此外,我们评估了研究期间的摄影变化和症状。结果:两组患者LPPAI均值在随访期间均下降,且变化规律相似。两个干预组的LPPAI评分无统计学差异。在随访期间,我们发现甲氨蝶呤组和联合治疗组在症状和摄影评估方面没有差异。在两组中,仅报告了一个不良反应。结论:我们的研究结果表明甲氨蝶呤联合和不联合皮质类固醇治疗具有相似的疗效和安全性。
{"title":"Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone versus Oral Methotrexate in Patients with Lichen Planopilaris.","authors":"Farahnaz Fatemi,&nbsp;Farifteh Esfahanian,&nbsp;Ali Asilian,&nbsp;Fatemeh Mohaghegh,&nbsp;Mina Saber","doi":"10.1155/2022/3792489","DOIUrl":"https://doi.org/10.1155/2022/3792489","url":null,"abstract":"<p><strong>Background: </strong>Lichen planopilaris (LPP) is a rare inflammatory disorder of the scalp that causes cicatricial alopecia. No therapeutic approach has been approved for this disease due to the rare frequency. Methotrexate and corticosteroid are commonly considered second- or third-line therapy. The efficacy of a combination of methotrexate and corticosteroid has been reported in some dermatological and immunological diseases. However, the efficacy of this combination in LPP is not clear. Therefore, this study aimed to compare the impact of methotrexate alone and in combination with corticosteroid on LPP.</p><p><strong>Materials and methods: </strong>This randomized clinical trial was performed on 28 patients who referred to the dermatology clinic affiliated with Isfahan University of Medical Sciences, Isfahan, Iran during February 2015-December 2016, and 24 of them completed the trials. Fourteen patients received 15 mg methotrexate per week alone and the other fourteen subjects received 200 mg prednisolone plus 15 mg methotrexate per week. The primary outcome was Lichen planopilaris activity index (LPPAI) score. Moreover, we evaluated photographic changes and symptoms during the study.</p><p><strong>Results: </strong>The mean of LPPAI in both groups decreased during the follow-up with a similar pattern of LPPAI changes in both groups. No statistically significant difference was found between the two intervention groups regarding the LPPAI score. We found no difference in the symptoms and photographic assessments in methotrexate and combination therapy groups during follow-up. In both groups, exclusively one adverse effect was reported.</p><p><strong>Conclusions: </strong>Our results showed that methotrexate therapy with and without corticosteroids had similar efficacy and safety.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":" ","pages":"3792489"},"PeriodicalIF":1.5,"publicationDate":"2022-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40321948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Efficacy of Lactocare® Synbiotic on the Clinical Symptoms in Patients with Psoriasis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Lactocare® Synbiotic 对银屑病患者临床症状的疗效:一项随机、双盲、安慰剂对照临床试验
IF 1.5 Q3 DERMATOLOGY Pub Date : 2022-10-07 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4549134
Ali Akbarzadeh, Pedram Alirezaei, Amin Doosti-Irani, Maryam Mehrpooya, Fatemeh Nouri

Background: Attention to the administration of probiotics for the treatment of psoriasis has recently increased.

Aim: In the present study, improvements in dermatology life quality index (DLQI), psoriasis area severity index (PASI), and visual analogue scale (VAS) scores in the psoriasis patients receiving Lactocare® probiotic were compared to psoriasis patients receiving placebo.

Methods: A total of 52 psoriasis patients were included in this study and randomly divided into treatment and placebo (control) groups. The control group received topical hydrocortisone associated with placebo; in the treatment group, Lactocare® was administrated orally associated with hydrocortisone. The mean of VAS, DLQI, and PSAI scores was recorded and evaluated pretreatment and post-treatment in both groups for 3 months. The mean of the scores in the control groups was compared to the treatment group. Intragroup analysis was preformed with a comparison of the mean of these scores at baseline 4-, 8-, and 12-weeks post-treatment.

Results: In the treatment group, a significant decrease was seen in PASI, VAS, and DLQI scores compared to the control group on week 12 post-treatment.

Conclusion: Oral administration of Lactocare® probiotic (two times daily) associated with administration of topical hydrocortisone resulted in the improvement of PASI, DLQI, and VAS scores in the patients with psoriasis after 12 weeks of treatment. PASI reduction occurred in all patients who received probiotics.

背景:最近,益生菌治疗银屑病的关注度有所上升:目的:在本研究中,比较了接受Lactocare®益生菌治疗的银屑病患者与接受安慰剂治疗的银屑病患者在皮肤科生活质量指数(DLQI)、银屑病面积严重程度指数(PASI)和视觉模拟量表(VAS)评分方面的改善情况:本研究共纳入了 52 名银屑病患者,并将其随机分为治疗组和安慰剂(对照)组。对照组局部使用氢化可的松和安慰剂;治疗组口服 Lactocare® 和氢化可的松。记录并评估两组患者在治疗前和治疗后 3 个月的 VAS、DLQI 和 PSAI 评分的平均值。对照组与治疗组的平均得分进行了比较。通过比较治疗后 4 周、8 周和 12 周的基线平均分,进行组内分析:结果:与对照组相比,治疗组在治疗后第12周的PASI、VAS和DLQI评分均有明显下降:结论:在口服 Lactocare® 益生菌(每天两次)并外用氢化可的松的同时,银屑病患者的 PASI、DLQI 和 VAS 评分在治疗 12 周后均有所改善。所有接受益生菌治疗的患者的 PASI 都有所下降。
{"title":"The Efficacy of Lactocare® Synbiotic on the Clinical Symptoms in Patients with Psoriasis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.","authors":"Ali Akbarzadeh, Pedram Alirezaei, Amin Doosti-Irani, Maryam Mehrpooya, Fatemeh Nouri","doi":"10.1155/2022/4549134","DOIUrl":"10.1155/2022/4549134","url":null,"abstract":"<p><strong>Background: </strong>Attention to the administration of probiotics for the treatment of psoriasis has recently increased.</p><p><strong>Aim: </strong>In the present study, improvements in dermatology life quality index (DLQI), psoriasis area severity index (PASI), and visual analogue scale (VAS) scores in the psoriasis patients receiving Lactocare® probiotic were compared to psoriasis patients receiving placebo.</p><p><strong>Methods: </strong>A total of 52 psoriasis patients were included in this study and randomly divided into treatment and placebo (control) groups. The control group received topical hydrocortisone associated with placebo; in the treatment group, Lactocare® was administrated orally associated with hydrocortisone. The mean of VAS, DLQI, and PSAI scores was recorded and evaluated pretreatment and post-treatment in both groups for 3 months. The mean of the scores in the control groups was compared to the treatment group. Intragroup analysis was preformed with a comparison of the mean of these scores at baseline 4-, 8-, and 12-weeks post-treatment.</p><p><strong>Results: </strong>In the treatment group, a significant decrease was seen in PASI, VAS, and DLQI scores compared to the control group on week 12 post-treatment.</p><p><strong>Conclusion: </strong>Oral administration of Lactocare® probiotic (two times daily) associated with administration of topical hydrocortisone resulted in the improvement of PASI, DLQI, and VAS scores in the patients with psoriasis after 12 weeks of treatment. PASI reduction occurred in all patients who received probiotics.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":" ","pages":"4549134"},"PeriodicalIF":1.5,"publicationDate":"2022-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33518903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fordyce Angiokeratoma: Comparison of Cryotherapy and Electrocauterization Treatments. 福代斯血管角化瘤:冷冻治疗与电灼治疗的比较。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2022-09-23 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2223602
Necmi Bayraktar

Fordyce angiokeratoma is a benign lesion commonly developing on the scrotal skin. The incidence increases with age. About half of these lesions may be symptomatic and frequently cause itching and bleeding. Although the treatment is not always considered necessary, several treatment methods are used for symptomatic cases, especially for cosmetic purposes. Treatment options include surgical excision, laser ablation, electrocoagulation, cryotherapy, and sclerotherapy. The most widely used methods are electrocoagulation and cryotherapy. Although these two methods are similarly effective and safe, there are differences in means of patient comfort and cosmetic outcomes. Patient comfort can be defined as pain management during the procedure and the healing period. Bleeding and wound infection are other parameters that may decrease patient comfort. Patients would prefer treatment methods with less or no pain and shorter recovery periods, healthcare providers, and insurance. The cosmetic result is another critical issue, especially for patients with multiple lesions. Treatment methods avoiding genital scars are more likely to meet the aesthetic demands of the patients.

福代斯血管角化瘤是一种常见于阴囊皮肤的良性病变。发病率随着年龄的增长而增加。大约一半的这些病变可能是有症状的,经常引起瘙痒和出血。虽然治疗并不总是被认为是必要的,但有几种治疗方法用于有症状的病例,特别是用于美容目的。治疗方案包括手术切除、激光消融、电凝、冷冻治疗和硬化治疗。使用最广泛的方法是电凝和冷冻疗法。虽然这两种方法同样有效和安全,但在患者舒适度和美容效果方面存在差异。患者舒适度可以定义为手术过程和愈合期间的疼痛管理。出血和伤口感染是其他可能降低患者舒适度的因素。患者更喜欢疼痛少或无疼痛、恢复期短的治疗方法、医疗保健提供者和保险。美容效果是另一个关键问题,特别是对于有多发病变的患者。避免生殖器疤痕的治疗方法更有可能满足患者的审美需求。
{"title":"Fordyce Angiokeratoma: Comparison of Cryotherapy and Electrocauterization Treatments.","authors":"Necmi Bayraktar","doi":"10.1155/2022/2223602","DOIUrl":"https://doi.org/10.1155/2022/2223602","url":null,"abstract":"<p><p>Fordyce angiokeratoma is a benign lesion commonly developing on the scrotal skin. The incidence increases with age. About half of these lesions may be symptomatic and frequently cause itching and bleeding. Although the treatment is not always considered necessary, several treatment methods are used for symptomatic cases, especially for cosmetic purposes. Treatment options include surgical excision, laser ablation, electrocoagulation, cryotherapy, and sclerotherapy. The most widely used methods are electrocoagulation and cryotherapy. Although these two methods are similarly effective and safe, there are differences in means of patient comfort and cosmetic outcomes. Patient comfort can be defined as pain management during the procedure and the healing period. Bleeding and wound infection are other parameters that may decrease patient comfort. Patients would prefer treatment methods with less or no pain and shorter recovery periods, healthcare providers, and insurance. The cosmetic result is another critical issue, especially for patients with multiple lesions. Treatment methods avoiding genital scars are more likely to meet the aesthetic demands of the patients.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":" ","pages":"2223602"},"PeriodicalIF":1.5,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33501242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profile of Transepidermal Water Loss (TEWL), Skin Hydration, and Skin Acidity (pH) in Indonesian Batik Workers. 印尼蜡染工人经皮失水(TEWL)、皮肤水合作用和皮肤酸度(pH)的概况。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2022-09-02 eCollection Date: 2022-01-01 DOI: 10.1155/2022/7014004
Cita Rosita Sigit Prakoeswa, Damayanti, Sylvia Anggraeni, Menul Ayu Umborowati, Sri Awalia Febriana, Katharina Oginawati, Ikeu Tanziha

Chemical substances used during batik processing may affect the physiological function of the batik worker's skin barrier. This study assessed the level of transepidermal water loss (TEWL), skin hydration, and skin acidity in 61 batik workers from the batik center in Paseseh village, Tanjung Bumi subdistrict, Madura Island, Indonesia. Forty-five batik workers involved in dry work including drawing patterns on the cloth with wax and sixteen batik workers involved in wet work including dyeing the cloth with a dye bath were included in this study. The mean TEWL level in the dry work section was 59.87 ± 11.94 g/m2/h on the palmar and 29.00 ± 13.09 g/m2/h on the dorsal side of the hand, while the mean TEWL in the wet work section were 47.39 ± 9.66 g/m2/h on the palmar and 37.07 ± 10.00 g/m2/h on the dorsal side of the hand. The mean skin hydration level in the dry work section was 49.80 ± 19.16 arbitrary units (a.u.) for the palmar side and 52.77 ± 16.21 a.u. for the dorsal side of the hand, while the mean levels of skin hydration in the wet work section were 47 ± 12.73 a.u. and 62.94 ± 10.09 a.u. for palmar and dorsal side, respectively. The mean levels of skin acidity in the dry work section were 5.45 ± 0.19 for the palmar side and 5.30 ± 0.20 for the dorsal side of the hand, while the wet work section had 5.30 ± 0.19 and 5.10 ± 0.19 for the palmar and dorsal side of the hand, respectively. The TEWL levels were found to be higher on the palmar side of the hand in both the dry work and wet work sections, which was consistent with the measurement of skin hydration levels that were lower on the palmar side of the hand. The mean skin pH levels for both work sections were considered within the normal range.

蜡染过程中使用的化学物质可能会影响蜡染工人皮肤屏障的生理功能。本研究评估了来自印度尼西亚马杜拉岛Tanjung Bumi街道Paseseh村蜡染中心的61名蜡染工人的经皮失水(TEWL)、皮肤水合作用和皮肤酸度水平。本研究包括45名从事干性工作(包括用蜡在布上绘制图案)的蜡染工人和16名从事湿性工作(包括用染料浴对布进行染色)的蜡染工人。干功区手掌平均TEWL为59.87±11.94 g/m2/h,手背平均TEWL为29.00±13.09 g/m2/h,湿功区手掌平均TEWL为47.39±9.66 g/m2/h,手背平均TEWL为37.07±10.00 g/m2/h。干操区手掌侧平均皮肤水合水平为49.80±19.16任意单位(a.u),手背侧平均皮肤水合水平为52.77±16.21任意单位(a.u),湿操区手掌侧平均皮肤水合水平为47±12.73 a.u,手背侧平均皮肤水合水平为62.94±10.09 a.u。干工作区手掌侧皮肤酸度平均值为5.45±0.19,手背侧皮肤酸度平均值为5.30±0.20,湿工作区手掌侧皮肤酸度平均值为5.30±0.19,手背侧皮肤酸度平均值为5.10±0.19。在干活儿和湿活儿中,手掌侧的TEWL水平都较高,这与手掌侧皮肤水合水平较低的测量结果一致。两个工作区域的平均皮肤pH值被认为在正常范围内。
{"title":"Profile of Transepidermal Water Loss (TEWL), Skin Hydration, and Skin Acidity (pH) in Indonesian Batik Workers.","authors":"Cita Rosita Sigit Prakoeswa,&nbsp;Damayanti,&nbsp;Sylvia Anggraeni,&nbsp;Menul Ayu Umborowati,&nbsp;Sri Awalia Febriana,&nbsp;Katharina Oginawati,&nbsp;Ikeu Tanziha","doi":"10.1155/2022/7014004","DOIUrl":"https://doi.org/10.1155/2022/7014004","url":null,"abstract":"<p><p>Chemical substances used during batik processing may affect the physiological function of the batik worker's skin barrier. This study assessed the level of transepidermal water loss (TEWL), skin hydration, and skin acidity in 61 batik workers from the batik center in Paseseh village, Tanjung Bumi subdistrict, Madura Island, Indonesia. Forty-five batik workers involved in dry work including drawing patterns on the cloth with wax and sixteen batik workers involved in wet work including dyeing the cloth with a dye bath were included in this study. The mean TEWL level in the dry work section was 59.87 ± 11.94 g/m<sup>2</sup>/h on the palmar and 29.00 ± 13.09 g/m<sup>2</sup>/h on the dorsal side of the hand, while the mean TEWL in the wet work section were 47.39 ± 9.66 g/m<sup>2</sup>/h on the palmar and 37.07 ± 10.00 g/m<sup>2</sup>/h on the dorsal side of the hand. The mean skin hydration level in the dry work section was 49.80 ± 19.16 arbitrary units (a.u.) for the palmar side and 52.77 ± 16.21 a.u. for the dorsal side of the hand, while the mean levels of skin hydration in the wet work section were 47 ± 12.73 a.u. and 62.94 ± 10.09 a.u. for palmar and dorsal side, respectively. The mean levels of skin acidity in the dry work section were 5.45 ± 0.19 for the palmar side and 5.30 ± 0.20 for the dorsal side of the hand, while the wet work section had 5.30 ± 0.19 and 5.10 ± 0.19 for the palmar and dorsal side of the hand, respectively. The TEWL levels were found to be higher on the palmar side of the hand in both the dry work and wet work sections, which was consistent with the measurement of skin hydration levels that were lower on the palmar side of the hand. The mean skin pH levels for both work sections were considered within the normal range.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":" ","pages":"7014004"},"PeriodicalIF":1.5,"publicationDate":"2022-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33460708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of a Simple Model to Predict the Risk of Nonmelanoma Skin Cancer on Screening Total Body Skin Examination. 建立和验证一个简单的模型来预测非黑色素瘤皮肤癌的风险筛选全身皮肤检查。
IF 1.5 Q3 DERMATOLOGY Pub Date : 2022-08-16 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2313896
Rebecca I Hartman, Yun Xue, Ryan Karmouta, Elizabeth Tkachenko, Sara J Li, David G Li, Cara Joyce, Arash Mostaghimi

Objective: There is insufficient evidence to generate skin cancer screening guidelines at the population level, resulting in arbitrary variation in patient selection for screening skin examinations. This study was aimed at developing an easy-to-use predictive model of nonmelanoma skin cancer (NMSC) risk on screening total body skin examination (TBSE).

Methods: This epidemiologic assessment utilized data from a prospective, multicenter international study from primarily academic outpatient dermatology clinics. Potential predictors of NMSC on screening TBSE were identified and used to generate a multivariable model that was converted into a point-based scoring system. The performance characteristics of the model were validated in a second data set from two healthcare institutions in the United States.

Results: 8,501 patients were included. Statistically significant predictors of NMSC on screening TBSE included age, skin phototype, and history of NMSC. A multivariable model and point-based scoring system using these predictors exhibited high discrimination (AUC = 0.82).

Conclusion: A simple three-variable model, abbreviated as CAP (cancer history, age, phototype) can accurately predict the risk of NMSC on screening TBSE by dermatology. This tool may be used in clinical decision making to enhance the yield of screening TBSE.

目的:在人群水平上制定皮肤癌筛查指南的证据不足,导致筛查皮肤检查患者选择的随意性变化。本研究旨在开发一种易于使用的非黑色素瘤皮肤癌(NMSC)风险预测模型,用于筛查全身皮肤检查(TBSE)。方法:这项流行病学评估利用了一项前瞻性、多中心的国际研究数据,主要来自学术门诊皮肤科诊所。确定了NMSC筛查TBSE的潜在预测因子,并用于生成多变量模型,该模型转化为基于积分的评分系统。该模型的性能特征在来自美国两家医疗机构的第二个数据集中得到验证。结果:共纳入8501例患者。有统计学意义的NMSC筛查TBSE的预测因子包括年龄、皮肤光型和NMSC病史。使用这些预测因子的多变量模型和基于点数的评分系统显示出高判别性(AUC = 0.82)。结论:一个简单的三变量模型,缩写为CAP(癌史、年龄、光型)可以准确预测皮肤病学筛查TBSE时NMSC的风险。该工具可用于临床决策,以提高筛查TBSE的产量。
{"title":"Development and Validation of a Simple Model to Predict the Risk of Nonmelanoma Skin Cancer on Screening Total Body Skin Examination.","authors":"Rebecca I Hartman,&nbsp;Yun Xue,&nbsp;Ryan Karmouta,&nbsp;Elizabeth Tkachenko,&nbsp;Sara J Li,&nbsp;David G Li,&nbsp;Cara Joyce,&nbsp;Arash Mostaghimi","doi":"10.1155/2022/2313896","DOIUrl":"https://doi.org/10.1155/2022/2313896","url":null,"abstract":"<p><strong>Objective: </strong>There is insufficient evidence to generate skin cancer screening guidelines at the population level, resulting in arbitrary variation in patient selection for screening skin examinations. This study was aimed at developing an easy-to-use predictive model of nonmelanoma skin cancer (NMSC) risk on screening total body skin examination (TBSE).</p><p><strong>Methods: </strong>This epidemiologic assessment utilized data from a prospective, multicenter international study from primarily academic outpatient dermatology clinics. Potential predictors of NMSC on screening TBSE were identified and used to generate a multivariable model that was converted into a point-based scoring system. The performance characteristics of the model were validated in a second data set from two healthcare institutions in the United States.</p><p><strong>Results: </strong>8,501 patients were included. Statistically significant predictors of NMSC on screening TBSE included age, skin phototype, and history of NMSC. A multivariable model and point-based scoring system using these predictors exhibited high discrimination (AUC = 0.82).</p><p><strong>Conclusion: </strong>A simple three-variable model, abbreviated as CAP (cancer history, age, phototype) can accurately predict the risk of NMSC on screening TBSE by dermatology. This tool may be used in clinical decision making to enhance the yield of screening TBSE.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":" ","pages":"2313896"},"PeriodicalIF":1.5,"publicationDate":"2022-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33438567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Dermatology Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1